An interesting study on mice that suggests Dutasteride may have neuro-protective properties in Parkinson's disease:
http://www.sciencedirect.com/science/article/pii/S0960076017302698
Highlights:
1. Dutasteride prevented the MPTP-induced striatal loss of dopamine contents.
2. Dutasteride prevented striatal MPTP-induced loss of DAT and VMAT2 transporters.
3. Dutasteride increased striatal DAT binding and glycosylation.
4. Dutasteride affected androgen and progesterone metabolism in brain and plasma.
5. Dutasteride prevented MPTP-induced increase of GFAP.
http://www.sciencedirect.com/science/article/pii/S0960076017302698
Highlights:
1. Dutasteride prevented the MPTP-induced striatal loss of dopamine contents.
2. Dutasteride prevented striatal MPTP-induced loss of DAT and VMAT2 transporters.
3. Dutasteride increased striatal DAT binding and glycosylation.
4. Dutasteride affected androgen and progesterone metabolism in brain and plasma.
5. Dutasteride prevented MPTP-induced increase of GFAP.